SearchDictionaryMobileLogin

Bengt Lindholm Selected Research

Chronic Kidney Failure (Chronic Renal Failure)

01/2006Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
10/2005Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.
01/2005Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease.
01/2005Role of interleukin-1beta in the development of malnutrition in chronic renal failure patients.
01/2005C-reactive protein in end-stage renal disease: are there reasons to measure it?
11/2004Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
07/2004Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease.
02/2004Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study.
06/2003Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
06/2003Update on interleukin-6 and its role in chronic renal failure.
05/2003A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.
09/2002Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
06/2002Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease.
05/2002Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?

Articles by Research Topic

Disease

14Inflammation
09/2008 - 01/2002
14Chronic Kidney Failure (Chronic Renal Failure)
01/2006 - 05/2002
12Kidney Diseases (Kidney Disease)
09/2008 - 10/2003
7Cardiovascular Diseases (Cardiovascular Disease)
09/2008 - 09/2002
6Malnutrition
01/2006 - 01/2002
2Syndrome
01/2008 - 01/2008
1Albuminuria
07/2008
1Diabetic Nephropathies (Diabetic Nephropathy)
05/2008
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2008
1Carotid Stenosis (Carotid Artery Stenosis)
01/2008
1Fibrosis (Cirrhosis)
01/2008
1Insulin Resistance
03/2007
1Basal Cell Carcinoma (Rodent Ulcer)
07/2005
1Uremia
04/2005
1Hepatitis C
12/2004
1Hyperhomocysteinemia
09/2004
1Diabetes Mellitus
09/2002
1Atherosclerosis (Atheroma)
05/2002
1Kidney Failure (Renal Failure)
03/2002
1Heart Diseases (Heart Disease)
01/2002

Drug/Important Bio-Agent (IBA)

4alpha-Fetoproteins (AFP)IBA
01/2008 - 01/2006
4Interleukin-6 (Interleukin 6)IBA
01/2006 - 05/2002
3HomocysteineIBA
09/2008 - 01/2007
3AdiponectinIBA
05/2008 - 07/2004
2PTX3 proteinIBA
07/2008 - 09/2007
2Biological Markers (Surrogate Marker)IBA
03/2008 - 09/2004
2C-Reactive ProteinIBA
01/2006 - 01/2005
2LeptinIBA
10/2005 - 10/2003
2IronIBA
07/2005 - 12/2004
2pentosidineIBA
12/2004 - 06/2003
2Peroxidase (Myeloperoxidase)IBA
11/2004 - 05/2003
2Amino AcidsFDA Link
09/2004 - 06/2002
2GhrelinIBA
02/2004 - 10/2003
1icodextrin (Extraneal)FDA Link
09/2008
1Glucose (Dextrose)FDA LinkGeneric
09/2008
1S-AdenosylhomocysteineIBA
09/2008
1Histidine (L-Histidine)FDA Link
06/2008
1Nicotinamide PhosphoribosyltransferaseIBA
03/2008
1Glycoproteins (Glycoprotein)IBA
01/2008
1sevelamer (RenaGel)FDA Link
01/2008
1Lactic AcidFDA LinkGeneric
01/2008
1Fibrinogen (Factor I)IBA
03/2007
18-oxo-7-hydrodeoxyguanosineIBA
11/2006
1Serum AlbuminIBA
01/2006
1Interleukin-10 (Interleukin 10)IBA
04/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2005
1AdipokinesIBA
01/2005
1Interleukin-1 (Interleukin 1)IBA
01/2005
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2005
1CytokinesIBA
10/2003
1Sulfur Amino AcidsIBA
09/2002
1TaurineFDA Link
03/2002

Therapy/Procedure

10Peritoneal Dialysis
01/2008 - 03/2003
3Renal Dialysis (Hemodialysis)
01/2008 - 01/2002
2Continuous Ambulatory Peritoneal Dialysis (CAPD)
01/2008 - 01/2008